PAEDIATRIC OBESITY PREVENTION, NUTRITION AND DIETETICS
With
Dr Robyn Littlewood, Chief Executive,
Health and Wellbeing Queensland & Adjunct Professor, University of Queensland, Queensland University of Technology & Griffith University, Australia
RESEARCHER PROFILE
Filmed in Brisbane, Australia | December 2025
Dr Robyn Littlewood is the CEO of Health and Wellbeing Queensland, the state’s prevention agency committed to fostering a healthier and more equitable Queensland.
With over 25 years of experience in clinical care, research and education, Dr Littlewood has made significant contributions to paediatric healthcare. Dr Littlewood is a published author with over 100 publications and has recently released her first book on health and wellbeing for Queensland. She has trained hundreds of students over two decades of frontline service.
Leveraging a systems-based and collaborative approach, Dr Littlewood continues to drive research and data outcomes in the area of health and wellbeing. Dr Littlewood leads a dedicated team focused on making healthy happen for all Queenslanders, with a particular focus on improving health outcomes for our next generation.
Dr Littlewood holds a raft of formal qualifications including a Bachelor of Science and Postgraduate Diploma in Nutrition and Dietetics, a Master of Medical Science, a Masters of Business Administration and a PhD. Dr Littlewood has also completed a number of postgraduate qualifications in executive leadership and is a member of the Australian Institute of Company Directors. Dr Littlewood holds Adjunct Professor appointments from UQ, QUT and Griffith universities, has been awarded Fellow of Dietitians Australia, the Barbara Chester Award and QUT Health Alumni of the year in recognition of her outstanding contribution to the dietetics profession.
Source: Supplied
https://orcid.org/0000-0002-9955-3662
-
Next generation nanomedicine and radiopharmaceuticals to treat cancer
Finding better ways of treating cancer, aside from finding a cure, aim to provide a better quality of life for those who suffer from it.
Professor Thurecht’s work focuses on nanomedicine and spans across the Australian Institute for Bioengineering and Nanotechnology and the Centre for Advanced Imaging, at the University of Queensland in Australia.
-
Targeting chemotherapy resistance in ovarian cancer patients
Dr Alex Cole, from the Centenary Institute’s Centre for Biomedical AI, is now leading the research focused on developing a new treatment to counteract a protein called follistatin (FST), known for making ovarian cancer cells resistant to chemotherapy.
By employing cutting-edge molecular biology and directed evolution techniques, the project aims to create nanobodies—small, precise molecules—that can block FST. If successful, these nanobodies could enhance the effectiveness of chemotherapy and improve ovarian cancer treatment rates.
-
Radiation therapy techniques and combination treatments for sarcoma
Professor Angela Hong MBBS, MMed, PhD, FRANZCR is a Professor at Sydney Medical School of the University of Sydney. She is a radiation oncologist and has been a member of the Multidisciplinary Bone and Soft Tissue Tumour Clinic at Royal Prince Alfred Hospital/Chris O’Brien Lifehouse for the past 15 years.
As a radiation oncologist located in Sydney, Australia, Professor Hong is focused on treating patients with bone and soft tissue sarcoma. And as a clinician scientist, her research focuses on developing innovative radiation therapy technique and combination treatments to improve the outcome for patients with sarcoma.
